Using Meta-Analysis to Evaluate the Risk of AKI Associated with IVI Drugs

Shih-Chieh Shao Speaker Using Systematic Review and Meta-Analysis to Evaluate the Risk of AKI Associated with IVI DrugsIntravitreal anti-vascular endothelial growth factor (anti-VEGF) drugs are widely used to treat retinal diseases, but concerns remain regarding their potential systemic effects, including acute kidney injury (AKI). This presentation will demonstrate how systematic review and meta-analysis can be applied to evaluate rare safety outcomes associated with intravitreal therapies.

Kai-Cheng Chang Moderator